Skip to main content
Erschienen in: Clinical Rheumatology 2/2009

01.02.2009 | Original Article

Endothelial nitric oxide synthase T-786C polymorphism in rheumatoid arthritis: association with extraarticular manifestations

verfasst von: Claiton Viegas Brenol, José Artur Bogo Chies, João Carlos Tavares Brenol, Odirlei André Monticielo, Paulo Franciscatto, Felipe Birriel, Andrei Gibbon Neves, Ricardo Machado Xavier

Erschienen in: Clinical Rheumatology | Ausgabe 2/2009

Einloggen, um Zugang zu erhalten

Abstract

Several genetic factors were implicated in the pathogenesis of rheumatoid arthritis (RA). A case–control study was carried out to verify the associations of T-786C polymorphism in the promoter region of the endothelial nitric oxide synthase (eNOS) gene with RA. One hundred and five consecutive RA patients and 100 healthy controls were genotyped. The distribution of the T-786C genotype and alleles did not differ significantly between RA patients and controls. Nevertheless, the frequency of extraarticular manifestations was significantly greater among the carriers of the C/C genotype than among carriers of the T/C and T/T genotypes (P = 0.022). The C/C genotype was significantly associated with extraarticular manifestations compared with the T/T and T/C genotypes taken together (OR = 4.9, 95% CI = 1.3–18.9). The C allele was significantly associated with extraarticular manifestations of RA (P corr = 0.032). The results suggested the existence of an association between the T-786C polymorphism of the eNOS gene and extraarticular manifestations of RA.
Literatur
1.
Zurück zum Zitat Barton A, Ollier W (2002) Genetic approaches to the investigation of rheumatoid arthritis. Curr Opin Rheumatol 14:260–269PubMedCrossRef Barton A, Ollier W (2002) Genetic approaches to the investigation of rheumatoid arthritis. Curr Opin Rheumatol 14:260–269PubMedCrossRef
2.
Zurück zum Zitat Wordsworth P, Bell J (1991) Polygenic susceptibility in rheumatoid arthritis. Ann Rheum Dis 50:343–346PubMedCrossRef Wordsworth P, Bell J (1991) Polygenic susceptibility in rheumatoid arthritis. Ann Rheum Dis 50:343–346PubMedCrossRef
3.
Zurück zum Zitat Clancy RM, Amin AR, Abramson SB (1998) The role of nitric oxide in inflammation and immunity. Arthritis Rheum 41:1141–1151PubMedCrossRef Clancy RM, Amin AR, Abramson SB (1998) The role of nitric oxide in inflammation and immunity. Arthritis Rheum 41:1141–1151PubMedCrossRef
4.
Zurück zum Zitat Marsden PA, Heng HH, Scherer SW, Stewart RJ, Hall AV, Shi XM, Tsui LC, Schappert KT (1993) Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem 268:17478–17488PubMed Marsden PA, Heng HH, Scherer SW, Stewart RJ, Hall AV, Shi XM, Tsui LC, Schappert KT (1993) Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem 268:17478–17488PubMed
5.
Zurück zum Zitat Casas JP, Bautista LE, Humphries SE, Hingorani AD (2004) Endothelial nitric oxide synthase genotype and ischemic heart disease: meta-analysis of 26 studies involving 23028 subjects. Circulation 109:1359–1365PubMedCrossRef Casas JP, Bautista LE, Humphries SE, Hingorani AD (2004) Endothelial nitric oxide synthase genotype and ischemic heart disease: meta-analysis of 26 studies involving 23028 subjects. Circulation 109:1359–1365PubMedCrossRef
6.
Zurück zum Zitat Rossi GP, Maiolino G (2004) Do meta-analyses of association studies of endothelial nitric oxide synthase variants and ischemic heart disease provide conclusive answers? Circulation 110:e305–e306 (author reply e305–e306)PubMedCrossRef Rossi GP, Maiolino G (2004) Do meta-analyses of association studies of endothelial nitric oxide synthase variants and ischemic heart disease provide conclusive answers? Circulation 110:e305–e306 (author reply e305–e306)PubMedCrossRef
7.
Zurück zum Zitat Gonzalez-Gay MA, Llorca J, Sanchez E, Lopez-Nevot MA, Amoli MM, Garcia-Porrua C, Ollier WE, Martin J (2004) Inducible but not endothelial nitric oxide synthase polymorphism is associated with susceptibility to rheumatoid arthritis in northwest Spain. Rheumatology (Oxford) 43:1182–1185CrossRef Gonzalez-Gay MA, Llorca J, Sanchez E, Lopez-Nevot MA, Amoli MM, Garcia-Porrua C, Ollier WE, Martin J (2004) Inducible but not endothelial nitric oxide synthase polymorphism is associated with susceptibility to rheumatoid arthritis in northwest Spain. Rheumatology (Oxford) 43:1182–1185CrossRef
8.
Zurück zum Zitat Salvarani C, Casali B, Nicoli D, Farnetti E, Macchioni P, Catanoso MG, Chen Q, Bajocchi G, Boiardi L (2003) Endothelial nitric oxide synthase gene polymorphisms in giant cell arteritis. Arthritis Rheum 48:3219–3223PubMedCrossRef Salvarani C, Casali B, Nicoli D, Farnetti E, Macchioni P, Catanoso MG, Chen Q, Bajocchi G, Boiardi L (2003) Endothelial nitric oxide synthase gene polymorphisms in giant cell arteritis. Arthritis Rheum 48:3219–3223PubMedCrossRef
9.
Zurück zum Zitat Kim JU, Chang HK, Lee SS, Kim JW, Kim KT, Lee SW, Chung WT (2003) Endothelial nitric oxide synthase gene polymorphisms in Behcet’s disease and rheumatic diseases with vasculitis. Ann Rheum Dis 62:1083–1087PubMedCrossRef Kim JU, Chang HK, Lee SS, Kim JW, Kim KT, Lee SW, Chung WT (2003) Endothelial nitric oxide synthase gene polymorphisms in Behcet’s disease and rheumatic diseases with vasculitis. Ann Rheum Dis 62:1083–1087PubMedCrossRef
10.
Zurück zum Zitat Fatini C, Gensini F, Sticchi E, Battaglini B, Angotti C, Conforti ML, Generini S, Pignone A, Abbate R, Matucci-Cerinic M (2002) High prevalence of polymorphisms of angiotensin-converting enzyme (I/D) and endothelial nitric oxide synthase (Glu298Asp) in patients with systemic sclerosis. Am J Med 112:540–544PubMedCrossRef Fatini C, Gensini F, Sticchi E, Battaglini B, Angotti C, Conforti ML, Generini S, Pignone A, Abbate R, Matucci-Cerinic M (2002) High prevalence of polymorphisms of angiotensin-converting enzyme (I/D) and endothelial nitric oxide synthase (Glu298Asp) in patients with systemic sclerosis. Am J Med 112:540–544PubMedCrossRef
11.
Zurück zum Zitat Serrano NC, Paez C, Correa PA, Anaya JM (2004) Endothelial nitric oxide synthase gene polymorphism is associated with systemic lupus erythematosus. J Rheumatol 31:2163–2168PubMed Serrano NC, Paez C, Correa PA, Anaya JM (2004) Endothelial nitric oxide synthase gene polymorphism is associated with systemic lupus erythematosus. J Rheumatol 31:2163–2168PubMed
12.
Zurück zum Zitat Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMedCrossRef Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMedCrossRef
13.
Zurück zum Zitat Lahiri DK, Nurnberger JI Jr (1991) A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 19:5444PubMedCrossRef Lahiri DK, Nurnberger JI Jr (1991) A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 19:5444PubMedCrossRef
14.
Zurück zum Zitat Ordonez AJ, Carreira JM, Franco AG, Sanchez LM, Alvarez MV, Garcia EC (2000) Two expressive polymorphisms on the endothelial nitric oxide synthase gene (intron4, 27 bp repeat and -786 T/C) and the venous thromboembolism. Thromb Res 99:563–566PubMedCrossRef Ordonez AJ, Carreira JM, Franco AG, Sanchez LM, Alvarez MV, Garcia EC (2000) Two expressive polymorphisms on the endothelial nitric oxide synthase gene (intron4, 27 bp repeat and -786 T/C) and the venous thromboembolism. Thromb Res 99:563–566PubMedCrossRef
15.
Zurück zum Zitat Melchers I, Blaschke S, Hecker M, Cattaruzza M (2006) The -786C/T single-nucleotide polymorphism in the promoter of the gene for endothelial nitric oxide synthase: insensitivity to physiologic stimuli as a risk factor for rheumatoid arthritis. Arthritis Rheum 54:3144–3151PubMedCrossRef Melchers I, Blaschke S, Hecker M, Cattaruzza M (2006) The -786C/T single-nucleotide polymorphism in the promoter of the gene for endothelial nitric oxide synthase: insensitivity to physiologic stimuli as a risk factor for rheumatoid arthritis. Arthritis Rheum 54:3144–3151PubMedCrossRef
16.
Zurück zum Zitat Tanus-Santos JE, Desai M, Flockhart DA (2001) Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants. Pharmacogenetics 11:719–725PubMedCrossRef Tanus-Santos JE, Desai M, Flockhart DA (2001) Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants. Pharmacogenetics 11:719–725PubMedCrossRef
17.
Zurück zum Zitat Risch NJ (2000) Searching for genetic determinants in the new millennium. Nature 405:847–856PubMedCrossRef Risch NJ (2000) Searching for genetic determinants in the new millennium. Nature 405:847–856PubMedCrossRef
18.
Zurück zum Zitat Ueki Y, Miyake S, Tominaga Y, Eguchi K (1996) Increased nitric oxide levels in patients with rheumatoid arthritis. J Rheumatol 23:230–236PubMed Ueki Y, Miyake S, Tominaga Y, Eguchi K (1996) Increased nitric oxide levels in patients with rheumatoid arthritis. J Rheumatol 23:230–236PubMed
19.
Zurück zum Zitat Abramson SB, Amin AR, Clancy RM, Attur M (2001) The role of nitric oxide in tissue destruction. Best Pract Res Clin Rheumatol 15:831–845PubMedCrossRef Abramson SB, Amin AR, Clancy RM, Attur M (2001) The role of nitric oxide in tissue destruction. Best Pract Res Clin Rheumatol 15:831–845PubMedCrossRef
20.
Zurück zum Zitat Elewaut D, De Keyser F, De Wever N, Baeten D, Van Damme N, Verbruggen G, Cuvelier C, Veys EM (1998) A comparative phenotypical analysis of rheumatoid nodules and rheumatoid synovium with special reference to adhesion molecules and activation markers. Ann Rheum Dis 57:480–486PubMedCrossRef Elewaut D, De Keyser F, De Wever N, Baeten D, Van Damme N, Verbruggen G, Cuvelier C, Veys EM (1998) A comparative phenotypical analysis of rheumatoid nodules and rheumatoid synovium with special reference to adhesion molecules and activation markers. Ann Rheum Dis 57:480–486PubMedCrossRef
21.
Zurück zum Zitat Markenson JA (1991) Worldwide trends in the socioeconomic impact and long-term prognosis of rheumatoid arthritis. Semin Arthritis Rheum 21:4–12PubMedCrossRef Markenson JA (1991) Worldwide trends in the socioeconomic impact and long-term prognosis of rheumatoid arthritis. Semin Arthritis Rheum 21:4–12PubMedCrossRef
22.
Zurück zum Zitat Gonzalez-Gay MA, Gonzalez-Juanatey C, Ollier WE (2004) Endothelial dysfunction in rheumatoid arthritis: influence of HLA-DRB1 alleles. Autoimmun Rev 3:301–304PubMedCrossRef Gonzalez-Gay MA, Gonzalez-Juanatey C, Ollier WE (2004) Endothelial dysfunction in rheumatoid arthritis: influence of HLA-DRB1 alleles. Autoimmun Rev 3:301–304PubMedCrossRef
Metadaten
Titel
Endothelial nitric oxide synthase T-786C polymorphism in rheumatoid arthritis: association with extraarticular manifestations
verfasst von
Claiton Viegas Brenol
José Artur Bogo Chies
João Carlos Tavares Brenol
Odirlei André Monticielo
Paulo Franciscatto
Felipe Birriel
Andrei Gibbon Neves
Ricardo Machado Xavier
Publikationsdatum
01.02.2009
Verlag
Springer-Verlag
Erschienen in
Clinical Rheumatology / Ausgabe 2/2009
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-008-1018-6

Weitere Artikel der Ausgabe 2/2009

Clinical Rheumatology 2/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.